C Levenback

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. doi request reprint Update on sentinel lymph node biopsy in gynecologic cancers
    Charles Levenback
    MD Anderson Cancer Center, Houston, TX, USA
    Gynecol Oncol 111:S42-3. 2008
  2. pmc Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study
    Charles F Levenback
    Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 440, Houston, TX 77030, USA
    J Clin Oncol 30:3786-91. 2012
  3. pmc Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
    John J Kavanagh
    Telik, Inc, Palo Alto, CA, USA
    J Hematol Oncol 3:9. 2010
  4. pmc Status of sentinel lymph node biopsy in gynecological cancers
    Charles F Levenback
    Ann Surg Oncol 15:18-20. 2008
  5. ncbi request reprint Status of sentinel lymph nodes in cervical cancer
    Charles F Levenback
    The University of Texas M D Anderson Cancer Center, Department of Gynecologic Oncology, USA
    Gynecol Oncol 107:S18-9. 2007
  6. ncbi request reprint Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy
    Charles Levenback
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    J Clin Oncol 20:688-93. 2002
  7. doi request reprint Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008
    Charles F Levenback
    Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Gynecol Oncol 114:151-6. 2009
  8. ncbi request reprint Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer
    C Levenback
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Gynecol Oncol 83:276-81. 2001
  9. ncbi request reprint Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
    M Morris
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    N Engl J Med 340:1137-43. 1999
  10. ncbi request reprint Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix
    M Morris
    Department of Gynecologic Oncology, University of Texas, M D Anderson Cancer Center, Houston 77030, USA
    J Clin Oncol 16:1094-8. 1998

Detail Information

Publications37

  1. doi request reprint Update on sentinel lymph node biopsy in gynecologic cancers
    Charles Levenback
    MD Anderson Cancer Center, Houston, TX, USA
    Gynecol Oncol 111:S42-3. 2008
    ..Regional lymphadenectomy may no longer be a requirement in SLNB-negative patients if the SLN procedure is adequately validated in prospective clinical trials for gynecologic malignancies...
  2. pmc Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study
    Charles F Levenback
    Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 440, Houston, TX 77030, USA
    J Clin Oncol 30:3786-91. 2012
    ..To determine the safety of sentinel lymph node biopsy as a replacement for inguinal femoral lymphadenectomy in selected women with vulvar cancer...
  3. pmc Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
    John J Kavanagh
    Telik, Inc, Palo Alto, CA, USA
    J Hematol Oncol 3:9. 2010
    ..The primary endpoints were objective response rate (ORR) and progression-free survival (PFS)...
  4. pmc Status of sentinel lymph node biopsy in gynecological cancers
    Charles F Levenback
    Ann Surg Oncol 15:18-20. 2008
  5. ncbi request reprint Status of sentinel lymph nodes in cervical cancer
    Charles F Levenback
    The University of Texas M D Anderson Cancer Center, Department of Gynecologic Oncology, USA
    Gynecol Oncol 107:S18-9. 2007
  6. ncbi request reprint Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy
    Charles Levenback
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    J Clin Oncol 20:688-93. 2002
    ....
  7. doi request reprint Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008
    Charles F Levenback
    Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Gynecol Oncol 114:151-6. 2009
    ..This paper presents the opinion of the experts who participated regarding indications for SLNB, technical considerations, and directions for future investigation...
  8. ncbi request reprint Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer
    C Levenback
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Gynecol Oncol 83:276-81. 2001
    ..To determine the effectiveness of intraoperative lymphatic with blue dye alone as a means of localizing sentinel nodes in patients with vulvar cancer...
  9. ncbi request reprint Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
    M Morris
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    N Engl J Med 340:1137-43. 1999
    ..Patients were then to receive one or two applications of low-dose-rate intracavitary radiation, with a third cycle of chemotherapy planned for the second intracavitary procedure in the combined-therapy group...
  10. ncbi request reprint Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix
    M Morris
    Department of Gynecologic Oncology, University of Texas, M D Anderson Cancer Center, Houston 77030, USA
    J Clin Oncol 16:1094-8. 1998
    ..To evaluate the efficacy and toxicity of intravenous vinorelbine as single-agent chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the cervix...
  11. ncbi request reprint Sentinel nodes in gynecologic malignancies
    P T Ramirez
    Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Curr Opin Oncol 13:403-7. 2001
    ..The addition of novel techniques, such as histopathologic ultrastaging, immunohistochemistry staining, and reverse transcriptase polymerase chain reaction assays, will help increase the accuracy and rate of detection of disease...
  12. ncbi request reprint Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design
    K R Brader
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, USA
    J Clin Oncol 16:1879-84. 1998
    ..To identify characteristics that predict response to chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the cervix...
  13. ncbi request reprint Treatment of uterine papillary serous carcinoma with paclitaxel
    L Ramondetta
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, 77030, USA
    Gynecol Oncol 82:156-61. 2001
    ..The aim of this study was to determine the effectiveness and toxicity of monthly treatment with intravenous paclitaxel for women with advanced or recurrent uterine papillary serous carcinoma (UPSC)...
  14. ncbi request reprint Sigmoid perforation following radiation therapy in patients with cervical cancer
    P T Ramirez
    Department of Gynecologic Oncology, The University of Texas M. D, Houston, Texas, 77030, USA
    Gynecol Oncol 82:150-5. 2001
    ..A high degree of suspicion remains a priority in the care of radiated patients who present with abdominal pain given the atypical presentation of perforation in this group...
  15. ncbi request reprint Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study
    L M Ramondetta
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Gynecol Cancer 14:580-8. 2004
    ..Expanding our understanding of what motivates GOs to recommend continued treatment over palliation is important for preserving informed patient-motivated end-of-life decisions...
  16. ncbi request reprint Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix
    P J Eifel
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Gynecol Cancer 16:1106-11. 2006
    ..The relatively stable annual actuarial risk between 3 and 25 years and the better survival rate after late CDR suggest that most "recurrences" after 3 years are actually new neoplasms...
  17. ncbi request reprint Salvage chemotherapy for refractory transitional cell carcinoma of the ovary (TCC)
    K M Sweeten
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Gynecol Oncol 59:211-5. 1995
    ..The purpose of this study was to determine the responsiveness of refractory ovarian TCC to salvage chemotherapy...
  18. ncbi request reprint Laparoscopic port-site metastases in patients with gynecological malignancies
    P T Ramirez
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Gynecol Cancer 14:1070-7. 2004
    ..The purpose of this study is to review all reported cases of laparoscopic port-site metastases in patients with gynecological malignancies. Potential etiologies as well as options for prevention are discussed...
  19. ncbi request reprint Posttherapy surveillance of women with cervical cancer: an outcomes analysis
    D Bodurka-Bevers
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Gynecol Oncol 78:187-93. 2000
    ..The aim of this study was to develop a surveillance program that optimizes clinical outcome following primary treatment of women with cervical cancer...
  20. ncbi request reprint Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix
    C F Verschraegen
    Multidisciplinary Center of Gynecology Oncology, Section of Gynecologic and Medical Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 92:2327-33. 2001
    ..The activity of the combination of carboplatin and liposomal doxorubicin was tested in a Phase II study of patients with recurrent cervical carcinoma...
  21. ncbi request reprint Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers
    Robert L Coleman
    Department of Gynecologic Oncology, Pathology, and Gynecologic Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 101:126-31. 2006
    ..To evaluate the efficacy and tolerability of imatinib mesylate (Gleevec; Novartis Pharmaceuticals, Basel, Switzerland) in patients with recurrent ovarian and primary peritoneal cancer...
  22. ncbi request reprint Is lymphatic mapping in uterine cancer feasible?
    Michael Frumovitz
    Ann Surg Oncol 15:1815-7. 2008
  23. doi request reprint Lymphatic mapping and sentinel lymph node detection in women with cervical cancer
    Michael Frumovitz
    Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 110:S17-20. 2008
    ..Large, multi-institutional studies in both Europe and the United States are nearing completion and their results should help guide the future direction for sentinel node technologies in the treatment of cervical cancer...
  24. ncbi request reprint Lymphatic mapping and sentinel node biopsy in vulvar, vaginal, and cervical cancers
    Michael Frumovitz
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Oncology (Williston Park) 22:529-36; discussion 538-9, 542-3. 2008
    ..Large validation studies are currently underway in both the United States and Europe. In this review article, we present the published data on mapping techniques and discuss future considerations for these technologies...
  25. doi request reprint Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma
    Elizabeth D Euscher
    Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 32:1336-43. 2008
    ..25%. Negative SLN predicts negative non-SLN. For most patients with a positive SLN, the SLN will be the only metastasis detected; a minority of patients with a positive SLN may have a positive non-SLN...
  26. ncbi request reprint The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva
    Angela Katz
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 57:409-18. 2003
    ..To evaluate treatment of the inguinal nodes for patients with squamous cell carcinoma of the vulva...
  27. ncbi request reprint How safe is sentinel lymph node biopsy in patients with vulvar cancer?
    Charles F Levenback
    J Clin Oncol 26:828-9. 2008
  28. doi request reprint Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer
    Michael Frumovitz
    Department of Gynecologic Oncology, CPB6 3244, Unit 1362, The University of Texas M D Anderson Cancer Center, 1155 Herman Pressler, Houston, TX 77030, USA
    Gynecol Oncol 108:478-81. 2008
    ..To determine the patterns of lymphatic drainage from primary vaginal cancers utilizing lymphoscintigraphy and to determine if this clinical information would affect treatment planning...
  29. ncbi request reprint A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets
    Lois M Ramondetta
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Gynecol Oncol 90:529-36. 2003
    ..The aim of this study was to determine the efficacy of cisplatin, ifosfamide, and mesna in uterine malignant mixed müllerian tumor (MMMT) and to evaluate the expression of clinically relevant molecular markers...
  30. ncbi request reprint Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment
    Mylin A Torres
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 70:118-25. 2008
    ..To compare the treatment and outcomes of cervical cancer patients treated with concurrent chemoradiotherapy (CT-RT) in a multi-institutional trial or as standard care...
  31. ncbi request reprint Imaging in cervical cancer
    Michele Follen
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 98:2028-38. 2003
    ..Advances in imaging methods and in contrast agents, along with advances in the combined use of the two, are expected to make imaging technologies more valuable in cervical cancer assessment...
  32. ncbi request reprint Has the time come for sentinel lymph node biopsy alone in radical hysterectomy patients?
    Charles F Levenback
    Gynecol Oncol 105:283-4. 2007
  33. ncbi request reprint Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary
    David R Crotzer
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 105:404-8. 2007
    ..The purpose of this study was to review our experience with recurrent clear cell carcinoma of the ovary to evaluate its responsiveness to systemic cytotoxic and hormonal agents...
  34. ncbi request reprint Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer
    Michael Frumovitz
    Department of Gynecologic Oncology, CPB6 3244, Unit 1362, The University of Texas M D Anderson Cancer Center, 1155 Herman Pressler, TX 77030, USA
    Gynecol Oncol 104:100-3. 2007
    ..To evaluate fundal injection of blue dye and radiocolloid for lymphatic mapping and sentinel node identification in women with high-risk endometrial cancer...
  35. ncbi request reprint Current perspectives on lymphatic mapping in carcinomas of the uterine corpus and cervix
    Robert L Coleman
    Department of Gynecologic Oncology, University of Texas, M D Anderson Cancer Center, 1155 Herman Pressler Drive, CPB 6 3271, Houston, TX 77030, USA
    J Natl Compr Canc Netw 4:471-8. 2006
    ..A consensus in corpus cancer has not been reached, although both sites are of keen interest with the increasing use of laparoscopy in surgical management. Prospective multi-institutional validation studies are underway...
  36. ncbi request reprint Quality of life and sexual functioning in cervical cancer survivors
    Michael Frumovitz
    Department of Gynecologic Oncology, 1155 Herman Pressler, CPB6 3244, Unit 1362, Houston, TX 77030, USA
    J Clin Oncol 23:7428-36. 2005
    ..To compare quality of life and sexual functioning in cervical cancer survivors treated with either radical hysterectomy and lymph node dissection or radiotherapy...
  37. ncbi request reprint Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancer
    Michael Frumovitz
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Obstet Gynecol 194:1186-93; discussion 1193-5. 2006
    ..The purpose of this study was to assess the value of preoperative lymphoscintigraphy before intraoperative lymphatic mapping for sentinel lymph node identification during radical hysterectomy...